Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation
Authors:
- 23 September 2011
- journal article
- Published by Springer Nature in Netherlands Heart Journal
- Vol. 19 (10) , 412-417
Abstract
To evaluate stent-related adverse cardiac events and bleeding complications within 30 days after surgical procedures in patients with recent drug-eluting stent (DES) implantation, in whom a bridging protocol was used. In our centre a bridging protocol is used in patients scheduled for cardiac or non-cardiac surgery within 6 months after PCI with DES implantation. Clopidogrel and in some cases also acetylsalicylic acid is discontinued 5 days prior to the planned intervention and patients are admitted 2 to 3 days before the intervention for tirofiban infusion. This is discontinued 4 h before intervention. Close postoperative monitoring is performed and double antiplatelet therapy is restarted as soon as possible. Thirty-six consecutive patients were included in the protocol, 15 receiving coronary artery bypass graft and 21 non-cardiac interventions. Thrombotic and bleeding complications were studied for up to 30 days after the bridged procedure. No incidences of stent thrombosis or other adverse cardiac events (mortality, myocardial infarction) were seen in up to 30 days of follow-up. However, 6 bleeding events were reported of which 5 required a blood transfusion. Our bridging protocol in patients requiring surgery after recent PCI with DES seems adequate to prevent stent thrombosis in this high-risk group. The bleeding risk is not insignificant but in our patient group controllable without major late sequelae. Larger studies should be performed to establish safety and efficacy in order to develop guidelines for these patients.Keywords
This publication has 31 references indexed in Scilit:
- Drug eluting stents are safe for licensed indications, FDA panel saysBMJ, 2006
- Risk of Noncardiac Surgery After Coronary Drug-Eluting Stent ImplantationThe American Journal of Cardiology, 2006
- Aortic Valve Regurgitation After Arterial Switch Operation for Transposition of the Great ArteriesJACC, 2006
- Coronary Stent Thrombosis in the Current Drug-Eluting Stent Era: Insights From the ERACI III TrialJACC, 2006
- Combined aspirin and clopidogrel in cataract surgical patients: a new risk factor for ocular haemorrhage?British Journal of Ophthalmology, 2004
- Avoidance of Bleeding During Surgery in Patients Receiving Anticoagulant and/or Antiplatelet TherapyClinical Pharmacokinetics, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Tirofiban therapy does not increase the risk of hemorrhage after emergency coronary surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2001
- Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteersBritish Journal of Clinical Pharmacology, 2001